These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 16033827)

  • 1. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
    Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
    Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
    Chow TF; Youssef YM; Lianidou E; Romaschin AD; Honey RJ; Stewart R; Pace KT; Yousef GM
    Clin Biochem; 2010 Jan; 43(1-2):150-8. PubMed ID: 19646430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
    Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [mRNA expression analysis of metastatic markers in clear-cell renal cell carcinoma].
    Struckmann K; Mertz K; Staller P; Krek W; Schraml P; Moch H
    Verh Dtsch Ges Pathol; 2005; 89():178-83. PubMed ID: 18035688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
    Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
    Burczynski ME; Twine NC; Dukart G; Marshall B; Hidalgo M; Stadler WM; Logan T; Dutcher J; Hudes G; Trepicchio WL; Strahs A; Immermann F; Slonim DK; Dorner AJ
    Clin Cancer Res; 2005 Feb; 11(3):1181-9. PubMed ID: 15709187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a microRNA panel for clear-cell kidney cancer.
    Juan D; Alexe G; Antes T; Liu H; Madabhushi A; Delisi C; Ganesan S; Bhanot G; Liou LS
    Urology; 2010 Apr; 75(4):835-41. PubMed ID: 20035975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
    Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel blood biomarkers of human urinary bladder cancer.
    Osman I; Bajorin DF; Sun TT; Zhong H; Douglas D; Scattergood J; Zheng R; Han M; Marshall KW; Liew CC
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3374-80. PubMed ID: 16740760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.
    Morikawa T; Sugiyama A; Kume H; Ota S; Kashima T; Tomita K; Kitamura T; Kodama T; Fukayama M; Aburatani H
    Clin Cancer Res; 2007 Oct; 13(19):5703-9. PubMed ID: 17908959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
    Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
    Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.